Patents by Inventor Avi Friedlich

Avi Friedlich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING LITHIUM
    Publication number: 20150342985
    Abstract: This invention relates to compositions comprising lithium and methods of their use.
    Type: Application
    Filed: December 27, 2013
    Publication date: December 3, 2015
    Inventor: Avi FRIEDLICH
  • Translation Enhancer Elements Of Genes Encoding Human Tau Protein and Human Alpha-Synuclein Protein
    Publication number: 20100151520
    Abstract: The invention relates to translation enhancer elements that enhance translation of the gene encoding the human microtubule-associated tau protein and nucleic acid molecules that enhance translation of the gene encoding the human ?-synuclein protein. The translation enhancer elements of the invention are useful in compositions and methods for identifying compounds for the prevention and/or treatment of neurodegenerative disease. The invention also includes in some aspects, vectors that include a translation enhancer element of the invention. The invention also includes the use of enhancer element containing vectors in methods to produce recombinant protein and in assays to identify compounds that modulate expression of tau protein or ?-synuclein protein.
    Type: Application
    Filed: December 15, 2009
    Publication date: June 17, 2010
    Inventors: Jack Rogers, Avi Friedlich
  • Translation enhancer elements of genes encoding human Tau protein and human alpha-synuclein protein
    Publication number: 20080003570
    Abstract: The invention relates to translation enhancer elements that enhance translation of the gene encoding the human microtubule-associated tau protein and nucleic acid molecules that enhance translation of the gene encoding the human ?-synuclein protein. The translation enhancer elements of the invention are useful in compositions and methods for identifying compounds for the prevention and/or treatment of neurodegenerative disease. The invention also includes in some aspects, vectors that include a translation enhancer element of the invention. The invention also includes the use of enhancer element containing vectors in methods to produce recombinant protein and in assays to identify compounds that modulate expression of tau protein or ?-synuclein protein.
    Type: Application
    Filed: December 22, 2005
    Publication date: January 3, 2008
    Applicant: The General Hospital Corporation
    Inventors: Jack Rogers, Avi Friedlich